Back
KalVista Pharmaceuticals Vs. Electromed Industry Stock Comparison
Sell
50
KALV
KalVista Pharmaceuticals
Last Price:
11.15
Seasonality Move:
4.45%
Buy
59
ELMD
Electromed
Last Price:
16.50
Seasonality Move:
2.98%
Sell
50
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $11.30. The Score for KALV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Electromed (ELMD)
is a Buy
Is Electromed a Buy, Sell or Hold?
- The current Electromed [ELMD] share price is $16.65. The Score for ELMD is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ELMD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $11.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.
ELMD Stock Price Chart
What is Electromed's stock price today?
-
The Electromed share price today is $16.65
The current trend is moderately bearish and ELMD is experiencing slight selling pressure.
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 40.96 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.12 - 12.24) | Sell |
| Bollinger Bands (100): | (11.3 - 14.02) | Sell |
ELMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.03 | Buy |
| Chaikin Money Flow: | -700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.3 - 17.6) | Sell |
| Bollinger Bands (100): | (11.6 - 17.2) | Buy |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.72 | Sell |
| 20-day SMA: | 11.88 | Sell |
| 50-day SMA: | 11.65 | Sell |
| 200-day SMA: | 11.13 | Buy |
| 8-day EMA: | 11.64 | Sell |
| 20-day EMA: | 11.75 | Sell |
| 50-day EMA: | 11.9 | Sell |
| 200-day EMA: | 11.34 | Sell |
ELMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.78 | Sell |
| 20-day SMA: | 17.15 | Sell |
| 50-day SMA: | 16.34 | Buy |
| 200-day SMA: | 12.41 | Buy |
| 8-day EMA: | 16.74 | Sell |
| 20-day EMA: | 16.76 | Sell |
| 50-day EMA: | 16.11 | Buy |
| 200-day EMA: | 13.42 | Buy |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.
Electromed Earnings Growth & ELMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
KalVista Pharmaceuticals Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Electromed Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||